Pharma Journalist -

Gan & Lee Pharmaceuticals Co., Ltd. a global biopharmaceutical company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, for…
Read More...

Rigel Pharmaceuticals, Inc. announced it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological…
Read More...

Takeda Pharmaceutical Company Limited announced the completion of its previously-announced sale of a portfolio of select products sold in Latin America to Hypera S.A. (“Hypera Pharma”)…
Read More...

Novartis announced that it has signed an initial agreement to leverage its manufacturing capacity and capabilities in order to address the COVID-19 pandemic by supporting the production…
Read More...

Novavax, Inc. announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial…
Read More...

Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, announced it has commenced production of its inactivated,…
Read More...

Eli Lilly and Company and Asahi Kasei Pharma Corporation announced a license agreement whereby Lilly will acquire the exclusive rights for AK1780 from Asahi Kasei Pharma. AK1780 is an…
Read More...

Hoth Therapeutics, Inc. announced extending a research collaboration agreement with Weill Cornell Medicine to continue investigating the therapeutic mechanism of action and safety of…
Read More...

Chronic and rare kidney disease drug development has been heating up as stakeholders bustle to deliver benefits beyond SGLT2s.  Already in January 2021, Bayer and AstraZeneca have been…
Read More...

Sanofi and BioNTech have entered into an agreement under which Sanofi will support manufacturing and supply of BioNTech’s COVID-19 vaccine which is being co-developed with Pfizer.…
Read More...